Literature DB >> 20180989

MALT lymphoma of the rectum, presenting with rectal prolapsus: a case report.

Feyzullah Ersoz1, Ahmet Burak Toros, Hasan Bektas, Ozhan Ozcan, Oguz Koc, Soykan Arikan.   

Abstract

Up to now, there have been only a few reported cases of Mucosa-associated lymphoid tissue (MALT) lymphomas arising in the rectum. Its clinical presentation is indistinguishable from that of rectal carcinoma but the treatment is apparently different. Symptoms of primary lymphomas involving the rectum include; anorexia, weight loss, change in bowel habits, obstruction, and bleeding. These symptoms are not disease specific and can be seen in many other gastrointestinal disorders. Patients with polypoid masses may present with obstruction symptoms. In this rare case, a female patient admitted to the emergency service with prolapsus of a rectal mass.The optimal treatment of rectal MALT lymphoma is not well defined yet, given the rarity of the disease. Surgical resection of the localized lesion and following adjuvant chemotherapy has proved to be an effective treatment option. However, a close and long-lasting follow-up is important.

Entities:  

Year:  2010        PMID: 20180989      PMCID: PMC2828431          DOI: 10.1186/1757-1626-3-33

Source DB:  PubMed          Journal:  Cases J        ISSN: 1757-1626


  19 in total

1.  Regression of MALT lymphoma of the rectum after anti-H. pylori therapy in a patient negative for H. pylori.

Authors:  F Inoue; T Chiba
Journal:  Gastroenterology       Date:  1999-08       Impact factor: 22.682

Review 2.  The gastric marginal zone B-cell lymphoma of MALT type.

Authors:  E Zucca; F Bertoni; E Roggero; F Cavalli
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

Review 3.  MALT lymphomas: a radiation oncology viewpoint.

Authors:  J Yahalom
Journal:  Ann Hematol       Date:  2001       Impact factor: 3.673

4.  Regression of salivary gland MALT lymphoma after treatment for Helicobacter pylori.

Authors:  S Alkan; D S Karcher; M A Newman; P Cohen
Journal:  Lancet       Date:  1996-07-27       Impact factor: 79.321

5.  Regression of mucosa-associated lymphoid-tissue lymphoma of rectum after eradication of Helicobacter pylori.

Authors:  T Matsumoto; M Iida; M Shimizu
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

6.  Mucosa-associated lymphoid tissue gastrointestinal and nongastrointestinal lymphoma behavior: analysis of 108 patients.

Authors:  C Thieblemont; Y Bastion; F Berger; C Rieux; G Salles; C Dumontet; P Felman; B Coiffier
Journal:  J Clin Oncol       Date:  1997-04       Impact factor: 44.544

7.  A case of MALT (mucosa-associated lymphoid tissue) lymphoma occurring in the rectum.

Authors:  M Orita; K Yamashita; M Okino; T Enoki; S Noshima; N Morita; K Esato
Journal:  Hepatogastroenterology       Date:  1999 Jul-Aug

8.  Antibiotic treatment is not effective in patients infected with Helicobacter pylori suffering from extragastric MALT lymphoma.

Authors:  Birgit Grünberger; Stefan Wöhrer; Berthold Streubel; Michael Formanek; Ventzislav Petkov; Andreas Puespoek; Michael Haefner; Michael Hejna; Ulrich Jaeger; Andreas Chott; Markus Raderer
Journal:  J Clin Oncol       Date:  2006-03-20       Impact factor: 44.544

9.  Malignant lymphoma of mucosa-associated lymphoid tissue.

Authors:  P G Isaacson; J Spencer
Journal:  Histopathology       Date:  1987-05       Impact factor: 5.087

10.  Successful treatment of mucosa-associated lymphoid tissue lymphoma of the rectum with radiation therapy: report of a case.

Authors:  Marcus Foo; Michael W T Chao; Peter Gibbs; Michael Guiney; Rodney Jacobs
Journal:  Dis Colon Rectum       Date:  2008-07-17       Impact factor: 4.585

View more
  2 in total

Review 1.  Mucosa-associated lymphoid tissue (MALT) variant of primary rectal lymphoma: a review of the English literature.

Authors:  Scott R Kelley
Journal:  Int J Colorectal Dis       Date:  2016-12-19       Impact factor: 2.571

Review 2.  Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas.

Authors:  Marta-Isabel Pereira; José Augusto Medeiros
Journal:  World J Gastroenterol       Date:  2014-01-21       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.